(2R,3S)-Piscidic acid



Compound IDCDAMM00724
Common name(2R,3S)-Piscidic acid
IUPAC name2,3-dihydroxy-2-[(4-hydroxyphenyl)methyl]butanedioic acid
Molecular formulaC11H12O7

Experimental data

Retention time9.64
Adduct[M+H]+
Actual mz257.065
Theoretical mz257.065
Error0.09
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.9543

Identifiers and class information

Inchi keyTUODPMGCCJSJRH-UHFFFAOYNA-N
SmilesO=C(O)C(O)C(O)(C(=O)O)CC1=CC=C(O)C=C1
SuperclassPhenylpropanoids and polyketides
ClassPhenylpropanoic acids

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)2
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)8
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)256.212
Computed dipole moment(dipole)2.118
Total solvent accessible surface area (SASA)444.341
Hydrophobic component of SASA (FOSA)41.255
Hydrophilic component of SASA (FISA)269.605
Pie component of the SASA (PISA)133.481
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)758.157
Number of hydrogen bond donors (donorHB)3
Number of hydrogen bond acceptors (accptHB)5.2
Free energy of solvation of dipole (dip^2/V)0.0059173
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0202697
Globularity descriptor (glob)0.904943
Predicted polarizability in cubic angstroms (QPpolrz)20.325
Predicted hexadecane/gas partition coefficient (QPlogPC16)8.965
Predicted octanol/gas partition coefficient (QPlogPoct)14.071
Predicted water/gas partition coefficient (QPlogPw)11.281
Predicted octanol/water partition coefficient (QPlogPo/w)1.03
Predicted aqueous solubility (QPlogS)-1.434
Conformation-independent predicted aqueous solubility (CIQPlogS)-2.706
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-0.092
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)1.764
Predicted brain/blood partition coefficient (QPlogBB)-2.114
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0.845
Predicted skin permeability, log Kp (QPlogKp)-5.25
PM3 calculated ionization potential (IP(ev))9.22
PM3 calculated electron affinity (EA(eV))-0.123
Number of likely metabolic reactions (#metab)4
Prediction of binding to human serum albumin (QPlogKhsa)-0.909
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)37.387
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)151.743
Number of nitrogen and oxygen atoms (#NandO)7
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P08473MMENeprilysinT05409SEA
P23280CA6Carbonic anhydrase VIT06569SEA
Q6B0I6KDM4DLysine-specific demethylase 4DT17036SEA
P80404ABATGamma-amino-N-butyrate transaminaseT59045SEA
Q92731ESR2Estrogen receptor betaT80896SEA
P07101THTyrosine 3-hydroxylaseT62390SEA
Q16719KYNUKynureninaseT99912SEA
P03372ESR1Estrogen receptor alphaT02506SEA
Q6P179ERAP2Endoplasmic reticulum aminopeptidase 2T65818SEA
Q86YT5SLC13A5Solute carrier family 13 member 5T81547SEA
Q9Y3Q0NAALAD2NAALADase IIT70036SEA
P53396ACLYATP-citrate synthaseT52189SEA
P12004PCNAProliferating cell nuclear antigenT21782SEA
P15169CPN1Carboxypeptidase N, catalytic subunitT34471SEA
P45974USP5Ubiquitin carboxyl-terminal hydrolase 5T17067SEA
P51649ALDH5A1Succinate semialdehyde dehydrogenaseT13259SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T05409DI0175Heart failure[ICD-11: BD10-BD1Z]P08473MME
T06569DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P23280CA6
T06569DI0372Seborrhoeic dermatitis[ICD-11: EA81]P23280CA6
T59045DI0060Brain cancer[ICD-11: 2A00]P80404ABAT
T59045DI0134Epilepsy/seizure[ICD-11: 8A61-8A6Z]P80404ABAT
T59045DI0135Epileptic encephalopathy[ICD-11: 8A62]P80404ABAT
T59045DI0266Mineral deficiency[ICD-11: 5B5K]P80404ABAT
T59045DI0306Nutritional deficiency[ICD-11: 5B50-5B71]P80404ABAT
T80896DI0062Breast cancer[ICD-11: 2C60-2C6Y]Q92731ESR2
T80896DI0108Cushing syndrome[ICD-11: 5A70]Q92731ESR2
T80896DI0254Menopausal disorder[ICD-11: GA30]Q92731ESR2
T80896DI0432Vasomotor/allergic rhinitis[ICD-11: CA08]Q92731ESR2
T62390DI0019Adrenomedullary hyperfunction[ICD-11: 5A75]P07101TH
T62390DI0306Nutritional deficiency[ICD-11: 5B50-5B71]P07101TH
T99912DI0046Bacterial infection[ICD-11: 1A00-1C4Z]Q16719KYNU
T99912DI0062Breast cancer[ICD-11: 2C60-2C6Y]Q16719KYNU
T02506DI0106COVID-19[ICD-11: 1D6Y]P03372ESR1
T52189DI0188Hyper-lipoproteinaemia[ICD-11: 5C80]P53396ACLY
T21782DI0308Obesity[ICD-11: 5B80-5B81]P12004PCNA
T17067DI0339Postoperative inflammation[ICD-11: 1A00-CA43]P45974USP5
T17067DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P45974USP5
T13259DI0122Diagnostic imaging[ICD-11: N.A.]P51649ALDH5A1
T13259DI0306Nutritional deficiency[ICD-11: 5B50-5B71]P51649ALDH5A1

Copyright © 2025